Durlax deploys Rs 7.89 crore on existing product lines

Durlax Top Surface Limited deployed Rs 7.89 crore from its Rs 49 crore preferential issue to expand and deepen existing product lines, including laminates and other products, by September 30, 2026. The same fund-use statement reported nil utilisation for the Rs 14.5 crore sanitaryware allocation and the Rs 16.5 crore DLZINC allocation.

What did Durlax disclose about preferential-issue fund use?

Durlax raised Rs 49 crore on June 26, 2026, and filed its statement of deviation or variation in utilisation of funds for the quarter ended September 30, 2026. The statement divides the preferential-issue proceeds among four original objects: sanitaryware, the DLZINC product launch, expansion of existing product lines, and general corporate purpose.

The filing records Rs 11.2586 crore of utilisation across two of those four objects by September 30, 2026. Existing product-line expansion received Rs 7.89 crore, while general corporate purpose received Rs 3.3686 crore. The statement identifies laminates and other products within the existing-lines object, but does not provide a product-wise split of the expenditure.

The reported pattern concentrated initial deployment in the existing-products category rather than the two separately named initiatives. Durlax had originally allocated Rs 14.5 crore to expand and deepen existing product lines, of which Rs 7.89 crore had been used by the September 30 reporting date.

How was Durlax's Rs 49 crore allocation divided?

Durlax allocated Rs 16.5 crore, its largest single allocation, to launching the DLZINC product. It allotted Rs 14.5 crore each to acquiring and investing in the sanitaryware business and to expanding and deepening existing product lines, while Rs 3.5 crore was designated for general corporate purpose.

The sanitaryware and DLZINC objects together accounted for Rs 31 crore of the Rs 49 crore issue, but both recorded nil utilisation at September 30, 2026. In contrast, the existing-product object recorded Rs 7.89 crore of use and the general-corporate-purpose object recorded Rs 3.3686 crore.

The comparison also shows different levels of deployment within the two funded categories. General corporate purpose had utilised Rs 3.3686 crore from its Rs 3.5 crore allocation, while existing product-line expansion had utilised Rs 7.89 crore from its Rs 14.5 crore allocation. The filing does not state the individual uses within either amount.

Which Durlax initiatives received funds by September 30, 2026?

Durlax funded existing product-line expansion and general corporate purpose by September 30, 2026, while sanitaryware and DLZINC received no reported funds. The Rs 7.89 crore product-line expenditure was linked to expanding and deepening existing lines, including laminates and other products.

The existing-product allocation differed from the two new initiatives in the same Rs 49 crore fund-use statement. The full Rs 14.5 crore allocated for sanitaryware remained unutilised, and the full Rs 16.5 crore designated for DLZINC also remained unutilised as of the quarter end.

Durlax did not disclose a timetable for acquiring or investing in the sanitaryware business, and it did not state a launch date for DLZINC. It also did not split the Rs 7.89 crore existing-product expenditure between laminates and the other products named in the stated object.

Did Durlax report a deviation or monitoring issue?

Durlax did not list a modified object, modified allocation or deviation amount for any of the four original objects in its September 30, 2026 statement. The filing marked the table concerning objects where there had been a deviation as not applicable, and recorded no comments from the Audit Committee or auditors.

The company also stated that a monitoring agency was not applicable to the Rs 49 crore fundraising completed on June 26, 2026. The absence of a modified allocation means the original Rs 14.5 crore, Rs 16.5 crore, Rs 14.5 crore and Rs 3.5 crore split remains the disclosed basis for tracking utilisation.

On that basis, Durlax reported spending in only two of four categories during the period to September 30, 2026. The Rs 31 crore combined allocation for sanitaryware and DLZINC had not been used, whereas Rs 11.2586 crore had been deployed across existing product lines and general corporate purpose.

Conclusion

Durlax's September 30, 2026 disclosure shows that its first reported use of the Rs 49 crore preferential issue focused on existing product lines rather than sanitaryware or DLZINC. Of the Rs 11.2586 crore deployed, Rs 7.89 crore went to expanding and deepening existing lines, including laminates and other products, while Rs 3.3686 crore went to general corporate purpose.

The next disclosed utilisation update will show whether Durlax begins deploying the Rs 14.5 crore reserved for sanitaryware and the Rs 16.5 crore allocated to DLZINC. The filing provides no acquisition timetable, DLZINC launch date or product-level split of the Rs 7.89 crore expenditure, leaving subsequent fund-use statements as the identified update point.